Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

This update describes an ongoing Phase 2/Phase 3 clinical trial evaluating BNT327 in combination with chemotherapy and other investigational agents for non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BNT327

Snippet

Sponsor: BioNTech SE | Conditions: Non-small Cell Lung Cancer | Phase 2, Phase 3 | Status: RECRUITING